Mauna Kea Technologies to Host a Webinar on July 21, 2026 To Discuss Its First-Half Business Activity

About this update from Mauna Kea Technologies Sa Class O

PARIS & BOSTON, July 16, 2026 --( BUSINESS WIRE )--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT) , inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, announces that it will host a webinar for its shareholders and the financial community on Tuesday, July 21, 2026. Sacha Loiseau , Chairman and Chief Executive Officer, and Côme de La Tour du Pin , Chief Financial Officer of the Company, will provide live commentary on the key highlights of the first half of 2026. The presentation will be followed by a Q&A session. Advance registration is required to participate in the event. Webinar for shareholders and investors – Tuesday, July 21 2026 5:50 pm. (CEST) – French Session: Click here to register A replay will be available for registered participants. About Mauna Kea Technologies Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time, assess point-in-time reactions as they happen in real time, classify indeterminate areas of concern, and guide surgical interventions. The Cellvizio® platform is used globally across a wide range of medical specialties and is making a transformative change in the way physicians diagnose and treat patients. For more information, visit www.maunakeatech.com . View source version on businesswire.com: https://www.businesswire.com/news/home/20260716753144/en/ Contacts Mauna Kea Technologies [email protected] NewCap - Investor Relations Thomas Grojean +33 (0)1 44 71 94 94 [email protected]

View stock analysis, news, and events for Mauna Kea Technologies Sa Class O